PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2009; 30(04): 121-123
DOI: 10.4103/0971-5851.65333
EDITORIAL

Pediatric oncology in India: Past, present and future

Autoren

  • Brijesh Arora

    Editor, IJMPO, Associate Professor, Division of Pediatric Oncology, Tata Memorial Hospital, Parel, Mumbai - 400 012, India

  • Sripad D Banavali

    Professor and Head, Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai - 400 012, India
Weitere Informationen
Auch verfügbar auf
 als PDF herunterladen Lizenzen und Reprints
Preview Container


Publikationsverlauf

Artikel online veröffentlicht:
19. November 2021

© 2009. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Gurney JG, Bondy ML. Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG, editors. Priciples and Practice of Pediatric Oncology. 5 th ed. Philadelphia; Lippincott Williams and Wilkins: 2006. p. 2-14.
  • 2 Barr R, Riberio R, Agarwal B, Masera G, Hesseling P, Magrath I. Pediatric Oncology in Countries with Limited Resources. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 5 th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 1605-17.
  • 3 Advani SH, Agarwal R, Venugopal P, Saikia TK. Pediatric oncology in India. Indian J Pediatr 1987;54:843-5.
  • 4 Shenoy S, Christo GG, Venkatesh A. Pediatric cancer care in India: A national survey. Indian J Cancer 1990;27:91-6.
  • 5 Arora R, Arora B. Delivering childhood cancer service across India: Current provisions and future options. Pediatr Blood Cancer 2009;53:827.
  • 6 Arora B, Kurkure P, Parikh P. Childhood cancers: Perspectives in India. J Indian Med Assoc 2005;103:479-82.
  • 7 Advani SH, Giri NK, Pai SK, Nair CN, Kurkure PA, Tapan SK, et al. Acute lymphoblastic leukemia in childhood: Treatment, results and prognostic factors. Indian J Cancer 1989;26:180-8.
  • 8 Magrath I, Shanta V, Advani S, Adde M, Arya LS, Banavali S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer 2005;41:1570-83.
  • 9 Gopal R, Advani SH, Arora S, Nair CN, Saikia TK, Pai SK, et al. Non-Hodgkin′s lymphoma in children: Clinical, histological and treatment analysis. Indian J Cancer 1987;24:202-9.
  • 10 Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, et al. Hodgkin′s disease in Indian children: outcome with chemotherapy alone. Pediatr Blood Cancer 2006;46:26-34.
  • 11 Swaminathan R, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990-2001: Incidence and survival. Int J Cancer 2008;122:2607-11.
  • 12 Nandakumar A, Anantha N, Appaji L, Swamy K, Mukherjee G, Venugopal T, et al. Descriptive epidemiology of childhood cancers in Bangalore, India. Cancer Causes Control 1996;7:405-10.
  • 13 Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009;46:257-66.
  • 14 Sarin R. Indian National Cancer Control Programme: Setting sight on shifting targets. J Cancer Res Ther 2005;1:240-8.
  • 15 Swaminathan R, Sankaranarayanan R. Under-diagnosis and under-ascertainment of cases may be the reasons for low childhood cancer incidence in rural India. Cancer Epidemiol 2010;34:107-8.
  • 16 Arora B, Kanwar V. Childhood cancers in India: Burden, barriers, and breakthroughs. Indian J Cancer 2009;46:257-9.
  • 17 George B, Mathews V, Poonkuzhali B, Shaji RV, Srivastava A, Chandy M. Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: A single center experience. Leukemia 2004;18:1587-90.
  • 18 Banavali S, Arora B, Kurkure PA, Pai S, Gujral S, Laskar S, et al. Improved outcome of children and young adults with T-cell acute lymphoblastic leukemia (T-All) with addition of high dose Ara-C (HDac). 40 th SIOP annual meeting abstracts D039; Pg.121.
  • 19 Stiller CA. Centralisation of treatment and survival rates of cancer. Arch Dis Child 1988;63:23-30.
  • 20 Crane K. Overcoming age limits in cancer clinical trials. NCI Cancer Bull 2010;7:8-9.
  • 21 Agarwal BR, Marwaha RK, Kurkure PA. Indian National Training Project Practical Paediatric Oncology (INTPPPO): 2 nd National teachers meeting, consensus report. Med Pediatr Oncol 2002;39:251.
  • 22 Pui CH, Schrappe M, Masera G, Nachman J, Gadner H, Eden OB, et al. Ponte di Legno Working Group: Statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 2004;18:1043-53.